share_log

LAVA Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

SEC ·  Jun 16, 2023 04:50
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.